About: Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adjuvant therapy for women with high-risk breast cancer     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 17 May 2010

AttributesValues
rdf:type
description
  • wetenschappelijk artikel (nl)
  • article scientifique publié en 2010 (fr)
  • наукова стаття, опублікована в травні 2010 (uk)
  • scientific article published on 17 May 2010 (en)
  • artículu científicu espublizáu en mayu de 2010 (ast)
publication date
publication date
author name string
author name string
  • Stephen Jones
  • Deborah Lindquist
  • Howard A Burris
  • Feng Zhan
  • Lina Asmar
  • David Loesch
  • Svetislava J Vukelja
  • Kristi A Boehm
  • Nicholas Robert
  • John D Hainsworth
  • F Anthony Greco
  • Manuel R Modiano
  • John Pippen
  • Kristi McIntyre
  • Scot Sedlacek
  • John Sandbach
  • Frankie Holmes
  • Neil N Senzer
rdfs:label
  • Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adjuvant therapy for women with high-risk breast cancer (en)
  • Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adjuvant therapy for women with high-risk breast cancer (nl)
skos:prefLabel
  • Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adjuvant therapy for women with high-risk breast cancer (en)
  • Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adjuvant therapy for women with high-risk breast cancer (nl)
name
  • Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adjuvant therapy for women with high-risk breast cancer (en)
  • Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adjuvant therapy for women with high-risk breast cancer (nl)
author
author
title
title
  • Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adjuvant therapy for women with high-risk breast cancer (en)
page(s)
page(s)
  • 2958-2965
instance of
instance of
main subject
main subject
PubMed ID
PubMed ID
PubMed ID
  • 20479419
published in
published in
issue
volume
issue
  • 18
volume
  • 28
DOI
DOI
DOI
  • 10.1200/JCO.2009.24.1000
is about of
is cites work of
is cites work of
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software